IMCR logo

Immunocore Holdings plc (IMCR)

Profile

Full Name

Immunocore Holdings plc

Ticker

NASDAQ: IMCR

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United Kingdom

IPO

February 5, 2021

Indexes

Not included

Website

https://www.immunocore.com

Employees

493

Key Details

Price

$39.50(-1.57%)

Market Cap

Last Dividend

-

TTM Dividend Yield

-

Annual Revenue

$310.33M(23.94% YoY)

Annual EPS

-$1.02(9.94% YoY)

PE Ratio

-

Next earnings date

Feb 25, 2026

Next ex-dividend date

N/A

Next split date

N/A

Quick Search

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    See Full Chart & Historical Data

    Analyst ratings

    Price

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Current Price

    $39.50
    IMCR price is $39.50

    30-Day Relative Volume

    0.32
    IMCR 30-day relative volume is 0.32

    Price Performance

    Price Most Recent Change

    -1.57%
    IMCR price was down -1.57% on Nov 28, 2025

    Price YTD Change

    +33.9%
    IMCR price is up +33.9% since January 1st

    Price 1-Year Change

    +20.65%
    IMCR price is up +20.65% year-on-year

    Price 3-Year Change

    -34.14%
    IMCR price is down -34.14% over the past 3 years

    Price Range

    Price All-Time High

    $76.98
    IMCR price is currently -48.69% below its historical high of $76.98

    Price 3-Year Low

    $23.15
    IMCR price is currently +70.63% above its 3-year low

    Capitalization

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Market cap

    Market Cap

    $2.00B
    IMCR market cap is $2.00 billion

    Market Cap 3-Year Change

    -30.54%
    IMCR market cap is down -30.54% over the past 3 years

    Market Cap All-Time High

    $3.75B
    IMCR market cap is currently -46.84% below its historical high of $3.75 billion

    Market Cap Sector Percentile

    79.32%
    IMCR market cap is higher than 79.32% of companies in Healthcare sector

    Shares Outstanding

    Shares Outstanding 1-Year Change

    +0.99%
    IMCR shares outstanding is up +0.99% year-on-year

    Shares Outstanding 3-Year Change

    +5.48%
    IMCR shares outstanding is up +5.48% over the past 3 years

    Technical Indicators

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Beta

    0.67
    IMCR beta is 0.67

    200-day SMA

    $32.51
    IMCR price is currently +21.51% above its 200-day simple moving average

    50-day SMA

    $34.59
    IMCR price is currently +14.19% above its 50-day simple moving average

    14-Day RSI

    67.98
    IMCR 14-day relative strength index is 67.98

    Volume

    0.32
    IMCR 30-day relative volume is 0.32

    ATR

    $1.52
    IMCR average true range is $1.52

    10-day Historical Volatility

    28.32%
    IMCR 10-day historical volatility is 28.32%

    Dividend

    Income Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Revenue

    Revenue

    $310.33M
    IMCR annual revenue is $310.33 million

    Revenue Analysts Estimate

    $403.14M
    IMCR annual revenue is currently -23.02% lower than the consensus analysts' forecast

    Revenue 1-Year Change

    +23.94%
    IMCR annual revenue is up +23.94% year-on-year

    Revenue Sector Percentile

    77.69%
    IMCR annual revenue is higher than 77.69% of companies in Healthcare sector

    EPS

    EPS

    -$1.02
    IMCR annual earnings per share is -$1.02

    EPS Analysts Estimate

    -$0.30
    IMCR annual earnings per share is currently -239.55% lower than the consensus analysts' forecast

    EPS 1-Year Change

    +9.94%
    IMCR annual earnings per share is up +9.94% year-on-year

    EPS Sector Percentile

    55.7%
    IMCR annual earnings per share is higher than 55.7% of companies in Healthcare sector

    Profit

    Gross Profit

    $307.47M
    IMCR annual gross profit is $307.47 million

    Gross Margin

    97.76%
    IMCR annual gross profit margin is 97.76%

    Operating Profit

    -$70.46M
    IMCR annual operating income is -$70.46 million

    Operating Margin

    -22.71%
    IMCR annual operating profit margin is -22.71%

    Net Income

    -$51.11M
    IMCR annual net profit is -$51.11 million

    Net Margin

    -16.47%
    IMCR annual net profit margin is -16.47%

    Expenses

    Total Expenses

    $380.66M
    IMCR annual total expenses is $380.66 million

    Operating Expenses

    $377.93M
    IMCR annual total operating expenses is $377.93 million

    Cost Of Goods Sold

    $6.94M
    IMCR annual cost of goods sold is $6.94 million

    Selling, General & Administrative Expenses

    $155.78M
    IMCR annual SG&A is $155.78 million

    Depreciation & Amortization

    $4.20M
    IMCR annual D&A is $4.20 million

    Interest Expense

    $18.84M
    IMCR annual interest expense is $18.84 million

    Income Tax

    -$1.85M
    IMCR annual income tax is -$1.85 million

    EBIT & EBITDA

    EBIT

    -$34.09M
    IMCR annual earnings before interest & taxes is -$34.09 million

    EBITDA

    -$29.89M
    IMCR annual EBITDA is -$29.89 million

    Balance Sheet

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Assets

    Total Assets

    $1.01B
    IMCR annual total assets is $1.01 billion

    Non Current Assets

    $79.64M
    IMCR annual long term assets is $79.64 million

    Current Assets

    $929.86M
    IMCR annual total current assets is $929.86 million

    Cash and Cash Equivalents

    $455.73M
    IMCR annual cash & cash equivalents is $455.73 million

    Accounts Receivable

    $63.01M
    IMCR annual accounts receivable is $63.01 million

    Inventory

    $5.45M
    IMCR annual inventory is $5.45 million

    Liabilities

    Total Liabilities

    $648.79M
    IMCR annual total liabilities is $648.79 million

    Long Term Liabilities

    $436.61M
    IMCR annual total long term liabilities is $436.61 million

    Current Liabilities

    $212.18M
    IMCR annual current liabilities is $212.18 million

    Accounts Payable

    $25.10M
    IMCR annual accounts payable is $25.10 million

    Debt

    Total Debt

    $432.72M
    IMCR annual total debt is $432.72 million

    Total Debt 1-Year Change

    +414.95%
    IMCR annual total debt is up +414.95% year-on-year

    Long Term Debt

    $431.18M
    IMCR annual long term debt is $431.18 million

    Short Term Debt

    $1.55M
    IMCR annual short term debt is $1.55 million

    Equity & Capital

    Shareholders Equity

    $360.72M
    IMCR annual stockholders equity is $360.72 million

    Book Value

    $360.72M
    IMCR annual book value is $360.72 million

    Retained Earnings

    -$795.76M
    IMCR annual retained earnings is -$795.76 million

    Working Capital

    $717.68M
    IMCR annual working capital is $717.68 million

    Cash Flow Statement

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Cashflow Activities

    Cash From Operations

    $26.06M
    IMCR annual cash from operations is $26.06 million

    Cash From Operations 1-Year Change

    +786.43%
    IMCR annual cash from operations is up +786.43% year-on-year

    Cash From Investing

    -$355.13M
    IMCR annual cash from investing is -$355.13 million

    Cash From Investing 1-Year Change

    -6446.16%
    IMCR annual cash from investing is down -6446.16% year-on-year

    Cash From Financing

    $343.88M
    IMCR annual cash from financing is $343.88 million

    Cash From Financing 1-Year Change

    +901.23%
    IMCR annual cash from financing is up +901.23% year-on-year

    CAPEX

    CAPEX

    $5.17M
    IMCR annual capital expenditures is $5.17 million

    CAPEX 1-Year Change

    -4.65%
    IMCR annual capital expenditures is down -4.65% year-on-year

    Free Cash Flow

    Free Cash Flow

    $20.89M
    IMCR annual free cash flow is $20.89 million

    Free Cash Flow 1-Year Change

    +940.56%
    IMCR annual free cash flow is up +940.56% year-on-year

    Profitability Ratios

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Margins

    Gross Margin

    97.76%
    IMCR annual gross profit margin is 97.76%

    Operating Margin

    -22.71%
    IMCR annual operating profit margin is -22.71%

    Net Margin

    -16.47%
    IMCR annual net profit margin is -16.47%

    ROA & ROE

    ROA

    -6.36%
    IMCR annual return on assets is -6.36%

    ROE

    -14.01%
    IMCR annual return on equity is -14.01%

    Valuation

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    PE Ratio

    PE Ratio

    -
    IMCR price to earnings ratio value is unknown

    PE Ratio Sector Percentile

    -
    IMCR price to earnings ratio is unknown

    PB Ratio

    PB Ratio

    5.06
    IMCR price to book ratio is 5.06

    PB Ratio Sector Percentile

    75.96%
    IMCR price to book ratio is higher than 75.96% of companies in Healthcare sector

    PS Ratio

    PS Ratio

    5.26
    IMCR price to sales ratio is 5.26

    PS Ratio Sector Percentile

    56.4%
    IMCR price to sales ratio is higher than 56.4% of companies in Healthcare sector

    Enterprise value

    Enterprise Value

    $1.54B
    IMCR enterprise value is $1.54 billion

    Enterprise Value Sector Percentile

    76.17%
    IMCR enterprise value is higher than 76.17% of companies in Healthcare sector

    EV/EBITDA

    EV/EBITDA

    -37.11
    IMCR EV/EBITDA is -37.11

    EV/EBITDA Sector Percentile

    4.02%
    IMCR EV/EBITDA is higher than 4.02% of companies in Healthcare sector

    Financial Health

    Add series to chart(max: 6)
    company, ETF, index, featured screener or watchlist
    series name
    Suggested series

    Liquidity

    Current Ratio

    4.38
    IMCR annual current ratio is 4.38

    Quick Ratio

    4.36
    IMCR annual quick ratio is 4.36

    Leverage

    Debt To Equity

    1.08
    IMCR annual debt to equity ratio is 1.08

    Interest Coverage Ratio

    -1.81
    IMCR annual interest coverage ratio is -1.81

    Risk & Stability

    F-Score

    5
    IMCR piotroski f-score is 5

    Altman Z-Score

    1.79
    IMCR altman z-score is 1.79

    Analyst ratings

    Recent major analysts updates

    Nov 10, 25 Morgan Stanley
    Equal-Weight
    Oct 31, 25 Wells Fargo
    Overweight
    Oct 22, 25 HC Wainwright & Co.
    Buy
    Jun 2, 25 HC Wainwright & Co.
    Buy
    May 8, 25 Oppenheimer
    Outperform
    Apr 14, 25 JP Morgan
    Overweight
    Apr 10, 25 Needham
    Buy
    Apr 7, 25 Mizuho
    Neutral
    Mar 12, 25 Needham
    Buy
    Mar 12, 25 HC Wainwright & Co.
    Buy

    Institutional Ownership

    Screeners with IMCR included

    Growing Shares Outstanding
    UK stocks
    Best performing stocks last month
    Most recommended stocks
    Best performing stocks last 3 months
    NASDAQ Dividend Calendar
    Stocks above SMA 50
    Stocks below analysts price target
    Healthcare sector
    All stocks
    • What is the ticker symbol for Immunocore Holdings plc?
    • Does Immunocore Holdings plc pay dividends?
    • What sector is Immunocore Holdings plc in?
    • What industry is Immunocore Holdings plc in?
    • What country is Immunocore Holdings plc based in?
    • When did Immunocore Holdings plc go public?
    • Is Immunocore Holdings plc in the S&P 500?
    • Is Immunocore Holdings plc in the NASDAQ 100?
    • Is Immunocore Holdings plc in the Dow Jones?
    • When was Immunocore Holdings plc's last earnings report?
    • When does Immunocore Holdings plc report earnings?

    What is the ticker symbol for Immunocore Holdings plc?

    The ticker symbol for Immunocore Holdings plc is NASDAQ:IMCR

    Does Immunocore Holdings plc pay dividends?

    No, Immunocore Holdings plc does not pay dividends

    What sector is Immunocore Holdings plc in?

    Immunocore Holdings plc is in the Healthcare sector

    What industry is Immunocore Holdings plc in?

    Immunocore Holdings plc is in the Biotechnology industry

    What country is Immunocore Holdings plc based in?

    Immunocore Holdings plc is headquartered in United Kingdom

    When did Immunocore Holdings plc go public?

    Immunocore Holdings plc's initial public offering (IPO) was on February 5, 2021

    Is Immunocore Holdings plc in the S&P 500?

    No, Immunocore Holdings plc is not included in the S&P 500 index

    Is Immunocore Holdings plc in the NASDAQ 100?

    No, Immunocore Holdings plc is not included in the NASDAQ 100 index

    Is Immunocore Holdings plc in the Dow Jones?

    No, Immunocore Holdings plc is not included in the Dow Jones index

    When was Immunocore Holdings plc's last earnings report?

    Immunocore Holdings plc's most recent earnings report was on November 6, 2025

    When does Immunocore Holdings plc report earnings?

    The next expected earnings date for Immunocore Holdings plc is February 25, 2026
    On this page